Clenpiq Liquid
NDC Package 55566-6800-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) liquids is sodium picosulfate/magnesium oxide/citric acid solution is used to clean out the intestines before surgery or certain procedures (such as colonoscopy, X-rays). This formulation utilizes a liquid delivery system. Marketed by Ferring Pharmaceuticals Inc., this product is identified by NDC 55566-6800 and is authorized under FDA application NDA209589.

Identification & Billing

NDC Package Code
55566-6800-2
Package Description
2 BOTTLE in 1 CARTON / 175 mL in 1 BOTTLE (55566-6800-0)
Product Code
55566-6800
11-Digit Billing Format
55566680002
RxNorm Crosswalk
  • RxCUI: 2626364 - citric acid 12 GM / magnesium oxide 3.5 GM / picosulfate sodium 10 MG in 175 mL Oral Solution
  • RxCUI: 2626364 - citric acid 68.6 MG/ML / magnesium oxide 20 MG/ML / picosulfate sodium 0.0571 MG/ML Oral Solution
  • RxCUI: 2626364 - citric acid 12 GM / magnesium oxide 3.5 GM / picosulfate sodium 10 MG per 175 ML Oral Solution
  • RxCUI: 2626366 - CLENPIQ 10 MG / 3.5 GM / 12 GM in 175 mL Oral Solution
  • RxCUI: 2626366 - citric acid 68.6 MG/ML / magnesium oxide 20 MG/ML / picosulfate sodium 0.0571 MG/ML Oral Solution [Clenpiq]

Clinical Specifications

Proprietary Name
Clenpiq
Non-Proprietary Name
Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid
Substance Name
Anhydrous Citric Acid; Magnesium Oxide; Sodium Picosulfate
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Sodium picosulfate/magnesium oxide/citric acid solution is used to clean out the intestines before surgery or certain procedures (such as colonoscopy, X-rays). It is a laxative that works by drawing large amounts of water into your intestines and stimulating the colon. This causes watery bowel movements (diarrhea). Clearing stool from the intestines helps your doctor to better examine the inside of your colon.

Regulatory & Marketing

Labeler Name
Ferring Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA209589
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-29-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
Yes

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55566-6800). Click a package code to view its specific billing and regulatory data.

55566-6800-1
2 BOTTLE in 1 CARTON / 175 mL in 1 BOTTLE (55566-6800-0)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55566-6800-2 identifies a specific commercial package of 2 bottle in 1 carton / 175 ml in 1 bottle (55566-6800-0) of Clenpiq, a human prescription drug labeled by Ferring Pharmaceuticals Inc.. This liquid is formulated for oral use and contains anhydrous citric acid; magnesium oxide; sodium picosulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ferring Pharmaceuticals Inc. on March 29, 2023. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Sodium picosulfate/magnesium oxide/citric acid solution is used to clean out the intestines before surgery or certain procedures (such as colonoscopy, X-rays). It is a laxative that works by drawing large amounts of water into your intestines and stimulating the colon. This causes watery bowel movements (diarrhea). Clearing stool from the intestines helps your doctor to better examine the inside of your colon.

How is this Ferring Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55566680002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55566-6800-2
11-Digit CMS (5-4-2)
55566-6800-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.